These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8737752)
1. Efficacy and safety of spirapril, a new ace-inhibitor, in elderly hypertensive patients. Kantola I; Terént A; Honkanen T; Järveläinen V; Ekman K; Kataja M Eur J Clin Pharmacol; 1996; 50(3):155-9. PubMed ID: 8737752 [TBL] [Abstract][Full Text] [Related]
2. 24-hour ambulatory blood pressure monitoring and spirapril in mild to severe essential hypertension: a randomized dose comparison. Vreugdenhil G; van Montfrans GA; Jacobs MC; de Bruijn JH; Veerman DP; van Es PN; Mellein B; Guitard C; Thien T; de Leeuw PW Blood Press Suppl; 1994; 2():23-30. PubMed ID: 8061842 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension. Pittrow DB; Antlsperger A; Welzel D; Wambach G; Schardt W; Weidinger G Cardiovasc Drugs Ther; 1997 Nov; 11(5):619-27. PubMed ID: 9493699 [TBL] [Abstract][Full Text] [Related]
4. A multicentre multidose study of the efficacy and safety of spirapril in mild-to-moderate essential hypertension. UK Study Group of Spirapril in Hypertension. Fairhurst GJ Blood Press Suppl; 1994; 2():77-80. PubMed ID: 8061852 [TBL] [Abstract][Full Text] [Related]
5. [Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS study)"]. Düsing R; Müller U MMW Fortschr Med; 2003 Oct; 145 Suppl 3():77-80. PubMed ID: 15490771 [TBL] [Abstract][Full Text] [Related]
6. Comparison of efficacy of spirapril and enalapril in control of mild-to-moderate hypertension. Guitard C; Lohmann FW; Alfiero R; Ruina M; Alvisi V Cardiovasc Drugs Ther; 1997 Jul; 11(3):449-57. PubMed ID: 9310273 [TBL] [Abstract][Full Text] [Related]
7. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response? van den Meiracker AH; Man in 't Veld AJ; Admiraal PJ; Ritsema van Eck HJ; Boomsma F; Derkx FH; Schalekamp MA J Hypertens; 1992 Aug; 10(8):803-12. PubMed ID: 1325513 [TBL] [Abstract][Full Text] [Related]
8. Single daily administration of spirapril in the treatment of essential hypertension. A multicentre double-blind comparison of 1, 6, 12 and 24 mg of spirapril once daily. Hayduk K; Schardt F; Sierakowski B; Weidinger G; Welzel D Blood Press Suppl; 1994; 2():41-6. PubMed ID: 8061845 [TBL] [Abstract][Full Text] [Related]
9. Placebo-controlled comparison of spirapril at 6, 12 and 24 mg/day in mild to severe essential hypertension. Guitard C; Alvisi V; Maibach E; Franck J; Cocco G; Boxho G; Mellein B; Waite R Blood Press Suppl; 1994; 2():81-7. PubMed ID: 8061853 [TBL] [Abstract][Full Text] [Related]
10. Low-dose reserpine/thiazide combination in first-line treatment of hypertension: efficacy and safety compared to an ACE inhibitor. Griebenow R; Pittrow DB; Weidinger G; Mueller E; Mutschler E; Welzel D Blood Press; 1997 Sep; 6(5):299-306. PubMed ID: 9360001 [TBL] [Abstract][Full Text] [Related]
11. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study. Hakamäki T; Lehtonen A Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336 [TBL] [Abstract][Full Text] [Related]
12. [Spirapril in the therapy of mild and moderately severe hypertension. A Czech and Slovak multicenter study]. Widimský J; Lánská V; Hulínský V Vnitr Lek; 1995 Nov; 41(11):744-52. PubMed ID: 8553592 [TBL] [Abstract][Full Text] [Related]
13. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study. Luque Otero M; Martell Claros N; Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479 [TBL] [Abstract][Full Text] [Related]
14. A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension. Nørgaard K; Jensen T; Christensen P; Feldt-Rasmussen B Blood Press; 1993 Dec; 2(4):301-8. PubMed ID: 8173700 [TBL] [Abstract][Full Text] [Related]
15. [Kidney function in hypertensive patients with chronic renal failure treated with the dual eliminated ACE-inhibitor spirapril]. Haufe CC; Sierakowski B; Jansa U; Stein G Med Klin (Munich); 1994 Aug; 89(8):416-20. PubMed ID: 7968874 [TBL] [Abstract][Full Text] [Related]
16. ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension. Petersen JR; Drabaek H; Gleerup G; Mehlsen J; Petersen LJ; Winther K Angiology; 1996 Mar; 47(3):233-40. PubMed ID: 8638865 [TBL] [Abstract][Full Text] [Related]
17. Spirapril. A preliminary review of its pharmacology and therapeutic efficacy in the treatment of hypertension. Noble S; Sorkin EM Drugs; 1995 May; 49(5):750-66. PubMed ID: 7601014 [TBL] [Abstract][Full Text] [Related]
18. Clinical experience with spirapril in human hypertension. Schmidt J; Kraul H J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 1():S25-30. PubMed ID: 10499561 [TBL] [Abstract][Full Text] [Related]
19. ACE-inhibitor therapy with spirapril increases nocturnal hypotensive episodes in elderly hypertensive patients. Kantola I; Terént A; Kataja M; Breig-Asberg E J Hum Hypertens; 2001 Dec; 15(12):873-8. PubMed ID: 11773991 [TBL] [Abstract][Full Text] [Related]